LEAMINGTON, ON, Jan. 8, 2019 /CNW/ - Aphria Inc.
("Aphria" or the "Company") (TSX:
APHA and NYSE: APHA) announced today that it has completed its first shipment of medical cannabis to
Shoppers Drug Mart ("SDM").
"As the first licensed producer to partner with Shoppers Drug Mart, we are pleased to have reached this milestone," said
Vic Neufeld, Chief Executive Officer of Aphria. "This marks another important step for medical
cannabis in Canada providing improved access for patients in need across the country. We are
thrilled that they now have the ability to access Aphria's renowned medical cannabis products through Shoppers Drug Mart's newly
launched ecommerce site – cannabis.shoppersdrugmart.ca."
"The potential cannabis has for medical purposes is still largely untapped and Aphria remains committed to investing in
developing new and innovative products that address unmet patient needs. For example, we will start to produce a thin,
quick-dissolve strip that may provide an effective and accurate dose delivery," added Neufeld.
The Company had previously announced a
supply agreement with Shoppers Drug Mart.
We Have A Good Thing Growing
About Aphria
Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation.
Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure
pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and
backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The
Company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer
segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term
shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in
more than 10 countries across 5 continents.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are not limited to, statements with respect to internal
expectations, estimated margins, expectations with respect to actual production volumes, expectations for future growing capacity
and costs, the completion of any capital project or expansions, and expectations with respect to future production costs.
Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with
general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory
developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or
inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed
will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
The forward-looking statements included in this news release are made as of the date of this news release and the Company does
not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
View original content to download multimedia:http://www.prnewswire.com/news-releases/aphria-completes-first-shipment-of-medical-cannabis-to-shoppers-drug-mart-300775317.html
SOURCE Aphria Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/08/c5103.html